I don't need to see videos to know that the machines and the cause is wonderful. What I don't like is the games people play instead of focusing all energies and synergies into increasing awareness of the product and focusing on sales and revenues and making a difference in womens' lives....when I see that happening on a grander scale, i'll join in the anthem
I do not understand a question? because buying something more expensive than its current price. I would understand if that option were a year ago and the price where it was and with prospects of staying, but now? because they do not buy 38 times cheaper? IMDS is irrelevant if in a month is worth 1 $ 5 $ or 20 $, nobody likes to lose money and buying to 0.0004 win more money than 0.015
Globe and Mail: IMDS Establishes Scientific Advisory Board
GlobeandMail (Canada's biggest newspaper)
Globe Investor
Imaging Diagnostic Systems Establishes Scientific Advisory Board
Monday, July 11, 2011 (FROM LAST YEAR but very good information about advisory BOARD MEMBERS)
FORT LAUDERDALE, Fla. (Business Wire) -- Imaging Diagnostic Systems, Inc., (OTCBB: IMDS) a pioneer in optical breast imaging, announced today that it has established a scientific advisory panel to assist with product advancement, future clinical studies and additional applications of its CT Laser Mammography breast imaging system.
The advisory panel will consist of leading physicians and scientists. IDSI will continue to expand the panel with medical and industry experts. The initial members are:
Huabei Jiang, Ph.D., J. Crayton Pruitt Professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida
Eric Milne, MD, FFR, FRCP, FRCP&S, was IDSI's Director of Clinical Research, former Chairman of Radiology and Chief of Chest Radiology at UC Irvine.
“The scientific advisory panel will be a valuable resource for IDSI in designing clinical studies, suggesting product improvements, and proposing new applications for CTLM technology. They will also assist with training development and participate in our international users meetings,” stated Dr. Steven Ponder, IDSI Director of Advanced Development.
About Imaging Diagnostic Systems, Inc.
Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis; indicative of breast cancer.
Imaging Diagnostic Systems is currently in the FDA approval process for the Computed Tomography Laser Mammography system. The CTLM system is limited by United States Federal Law to investigational use only in the United States. The CTLM system has received other registrations including CE, CMDCAS Canadian License, China SFDA, UL, ISO 9001:2000, ISO 13485:2003 and FDA export certification.
Market Data 
Markets 
AI
